JACQUELINE SKRUTVOLD: Open Payments
NPI 1306076435 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 49 payments from 21 companies in 2025. Trend: 2023 $577 · 2024 $1,576 · 2025 $1,166
Food & beverage: $1,091Education: $75
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $268 |
| AstraZeneca Pharmaceuticals LP | 4 | $115 |
| Daiichi Sankyo Inc. | 4 | $98 |
| Ipsen Biopharmaceuticals, Inc | 4 | $84 |
| SEAGEN INC. | 1 | $75 |
| Sumitomo Pharma America, Inc. | 3 | $74 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| ABBVIE INC. | 2 | $50 |
| GENZYME CORPORATION | 2 | $37 |
| SOBI, INC | 2 | $37 |
Products named: KISQALI, Enhertu, Fabhalta, Onivyde, ORGOVYX, EPKINLY, KEYTRUDA, AYVAKIT.
Industry payments across AZ — which companies pay providers there.
